Literature DB >> 11163822

Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors.

P Morice1, S Camatte, J El Hassan, P Pautier, P Duvillard, D Castaigne.   

Abstract

OBJECTIVE: To assess clinical outcome and fertility in patients treated conservatively for a low malignant potential (LMP) ovarian tumor.
DESIGN: Retrospective study.
SETTING: Gynecologic oncology department of a cancer care center in France. PATIENT(S): Forty-four patients treated with conservative management for a stage I (n = 32) or stage II or III (n = 12) LMP tumor. INTERVENTION(S): Thirty-three patients had unilateral adnexectomy and 11 had cystectomy. Cystectomy was bilateral in 1 patient and was done in conjunction with contralateral adnexectomy in 5 patients. MAIN OUTCOME MEASURE(S): Tumor recurrence and pregnancy rates. RESULT(S): Tumor recurrence rates after radical surgery (hysterectomy with bilateral salpingo-oophorectomy), adnexectomy, and cystectomy were 5.7%, 15.1%, and 36.3%, respectively (P<.01). Among patients who initially received conservative treatment, tumors did not recur in the form of invasive carcinoma. Five patients who had recurrence underwent repeated conservative management; these patients are alive and free of disease. Seventeen pregnancies (of which 15 were spontaneous) occurred in 14 patients; 13 pregnancies occurred in patients with stage I disease and 4 occurred in patients with stage III disease. CONCLUSION(S): Conservative management of LMP tumor significantly increases the risk of recurrence but does not affect overall survival. Such management offers even patients with advanced disease the chance to have spontaneous pregnancy. Conservative management might be proposed in young patients who wish to preserve their fertility, but careful follow-up will be required to detect tumor recurrence.

Entities:  

Mesh:

Year:  2001        PMID: 11163822     DOI: 10.1016/s0015-0282(00)01633-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  29 in total

1.  MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology.

Authors:  Marc Bazot; Jinane Nassar-Slaba; Isabelle Thomassin-Naggara; Annie Cortez; Serge Uzan; Emile Daraï
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

2.  Management of Borderline Ovarian Tumors-Still a Gray Zone.

Authors:  Nidhi Nayyar; Prerna Lakhwani; Ashish Goel; Pankaj Kr Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2017-08-25

Review 3.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

Review 4.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

5.  Risk factors for recurrence of ovarian borderline tumors.

Authors:  K K Shih; Q Zhou; J Huh; J C Morgan; A Iasonos; C Aghajanian; D S Chi; R R Barakat; N R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2010-12-10       Impact factor: 5.482

Review 6.  Interventions for the treatment of borderline ovarian tumours.

Authors:  Olusola Faluyi; Melanie Mackean; Charlie Gourley; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

7.  Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors.

Authors:  Karin K Shih; Qin C Zhou; Carol Aghajanian; Jae Huh; Robert A Soslow; Jessica C Morgan; Alexia Iasonos; Dennis S Chi; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2010-08-16       Impact factor: 5.482

8.  Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report.

Authors:  Ipsita Mohapatra; Subha R Samantaray; Nikku Harshini
Journal:  Cureus       Date:  2022-04-13

Review 9.  Management, prognosis and reproductive outcomes of borderline ovarian tumor relapse during pregnancy: from diagnosis to potential treatment options.

Authors:  Francesco Cosentino; Luigi Carlo Turco; Stefano Cianci; Francesco Fanfani; Anna Fagotti; Salvatore Gueli Alletti; Giuseppe Vizzielli; Salvatore Giovanni Vitale; Antonio Simone Laganà; Francesco Padula; Claudio Coco; Salvatore Pisconti; Giovanni Scambia
Journal:  J Prenat Med       Date:  2016 Jan-Jun

Review 10.  Primary and recurrent serous borderline tumors during pregnancy: a case report and literature review.

Authors:  Aya Matsumoto; Takuma Ito; Fumika Hamaguchi; Maya Kasuga; Teppei Mikami; Mayo Hino; Reiko Yokoyama; Shogo Yamamura; Harumi Sakata; Sachiko Minamiguchi; Masaki Mandai; Takaaki Yoshida
Journal:  Int Cancer Conf J       Date:  2021-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.